Genmab — Maj 2020
-
-
Trolmanden: 1 linie er med
-
troldmanden: in combination with bortezomib, melphalan and prednisone in newly diagnosed patients who are ineligible for autologous stem cell transplant (ASCT); in combination with lenalidomide and dexamethasone in newly diagnosed patients who are ineligible for ASCT and
-
-
Et stort knus til hustruen og dig.
-
Ja, men dara/rev/dex er den vigtige i US
-
En af de helt store dage! Det er sjældent at vi ser de helt store milestones, men det her er en af dem. Tillykke til Genmab og aktionærerne som tog risikoen
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind